Chronic kidney disease (CKD) patients are exposed to more proton pump inhibitor (PPI)s compared to non-CKD patients
Fig 1
Median values of total duration of PPI prescription during 2014–2015 by CKD groups (A), and duration prescribed at once by CKD groups(B). Fig 1A shows the CKD groups were prescribed significantly longer duration of PPIs than the non CKD group (p<0.001). Fig 1B shows the CKD stage5-ESRD group had significantly shorter duration of PPI prescribed at once than the other groups (p<0.001). †pair-wised comparisons were performed and p-value adjusted by bonfferoni correction.